(Q33385947)

26 July 2017

title

Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide (English)

1 reference

26 July 2017

1 reference

1 reference

Cafer Adiguzel

1

1 reference

26 July 2017

Omer Iqbal

2

1 reference

26 July 2017

Debra Hoppensteadt

3

1 reference

26 July 2017

Walter Jeske

4

1 reference

26 July 2017

Josephine Cunanan

5

1 reference

26 July 2017

Evangelos Litinas

6

1 reference

26 July 2017

He Zhu

7

1 reference

26 July 2017

Jeanine M Walenga

8

1 reference

26 July 2017

Jawed Fareed

9

1 reference

26 July 2017

publication date

23 August 2009

1 reference

Clinical and Applied Thrombosis-Hemostasis

26 July 2017

published in

1 reference

26 July 2017

volume

15

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

501-511

1 reference

Clinical uses of low-molecular-weight heparins

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Low-molecular-weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Low-molecular-weight heparins: pharmacologic profile and product differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Sulodexide: a renewed interest in this glycosaminoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

Anti-inflammatory effect of sulodexide during acute peritonitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609338711

21 January 2018

Identifiers

DOI

10.1177/1076029609338711

1 reference

26 July 2017

1 reference